Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients

Hydrogen has been shown to have antioxidant, anti-inflammatory, hormone-regulating, and apoptosis-resistance properties, among others. Based on a review of the research, the use of hydrogen might reduce the destructive cytokine storm and lung injury caused by SARS-CoV-2 during COVID-19 (Corona Virus...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fuxun, Yue, Ruiming, Luo, Xiaoxiu, Liu, Rongan, Huang, Xiaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593510/
https://www.ncbi.nlm.nih.gov/pubmed/33178011
http://dx.doi.org/10.3389/fphar.2020.543718
_version_ 1783601399022485504
author Yang, Fuxun
Yue, Ruiming
Luo, Xiaoxiu
Liu, Rongan
Huang, Xiaobo
author_facet Yang, Fuxun
Yue, Ruiming
Luo, Xiaoxiu
Liu, Rongan
Huang, Xiaobo
author_sort Yang, Fuxun
collection PubMed
description Hydrogen has been shown to have antioxidant, anti-inflammatory, hormone-regulating, and apoptosis-resistance properties, among others. Based on a review of the research, the use of hydrogen might reduce the destructive cytokine storm and lung injury caused by SARS-CoV-2 during COVID-19 (Corona Virus Disease 2019) in the early stage, stimulating ropy sputum drainage, and ultimately reducing the incidence of severe disease. Molecular hydrogen treatment has the potential to become a new adjuvant therapy for COVID-19, but its efficacy and safety require large clinical trials and further confirmation.
format Online
Article
Text
id pubmed-7593510
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75935102020-11-10 Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients Yang, Fuxun Yue, Ruiming Luo, Xiaoxiu Liu, Rongan Huang, Xiaobo Front Pharmacol Pharmacology Hydrogen has been shown to have antioxidant, anti-inflammatory, hormone-regulating, and apoptosis-resistance properties, among others. Based on a review of the research, the use of hydrogen might reduce the destructive cytokine storm and lung injury caused by SARS-CoV-2 during COVID-19 (Corona Virus Disease 2019) in the early stage, stimulating ropy sputum drainage, and ultimately reducing the incidence of severe disease. Molecular hydrogen treatment has the potential to become a new adjuvant therapy for COVID-19, but its efficacy and safety require large clinical trials and further confirmation. Frontiers Media S.A. 2020-10-15 /pmc/articles/PMC7593510/ /pubmed/33178011 http://dx.doi.org/10.3389/fphar.2020.543718 Text en Copyright © 2020 Yang, Yue, Luo, Liu and Huang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Yang, Fuxun
Yue, Ruiming
Luo, Xiaoxiu
Liu, Rongan
Huang, Xiaobo
Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients
title Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients
title_full Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients
title_fullStr Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients
title_full_unstemmed Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients
title_short Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients
title_sort hydrogen: a potential new adjuvant therapy for covid-19 patients
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593510/
https://www.ncbi.nlm.nih.gov/pubmed/33178011
http://dx.doi.org/10.3389/fphar.2020.543718
work_keys_str_mv AT yangfuxun hydrogenapotentialnewadjuvanttherapyforcovid19patients
AT yueruiming hydrogenapotentialnewadjuvanttherapyforcovid19patients
AT luoxiaoxiu hydrogenapotentialnewadjuvanttherapyforcovid19patients
AT liurongan hydrogenapotentialnewadjuvanttherapyforcovid19patients
AT huangxiaobo hydrogenapotentialnewadjuvanttherapyforcovid19patients

Ejemplares similares